2023年4期
亞洲社會(huì)藥學(xué)雜志
Pharmaceutical R&D
- Research on Incentive Policies for Chinese Innovative Drug R&D -Taking Innovative Anti-tumor Drugs as an Example
- Research on the Impact of Independent R&D and Collaborative Innovation on Economic Performance in China’s pharmaceutical Industry
- Research on the Effect of R&D lnvestment lntensity and Sales Expense on the Performance of Biomedical Enterprises
- The Status Quo and Enlightenment of the Foreign Extended Clinical Trial System
Pharmaceutical Quality Management
Public Affairs Administration
- Foreign Experience and Enlightenment of Reimbursement Management of Multi-indication Drugs
- Study on Public Health Behavior against the Background of COVID-19 Pandemic -Based on Bandura Reciprocal Determinism
- Inspiration of Foreign Innovative Drug Pricing Methods and Medical Insurance Payment Standards to China
- Current Situation and Prospect of the Application of Real-World Evidence in Health Care